Background: Limited information is known about the baseline frequency of canine CD20 positive ( ) cutaneous epitheliotropic T-cell lymphoma. A single canine case report has been published.
Objectives: To characterize the baseline frequency of CD20 staining in cases of canine cutaneous epitheliotropic T-cell lymphoma; to assess its values as a prognostic indicator.
Animals: Skin biopsies from 24 client-owned animals diagnosed with cutaneous epitheliotropic lymphoma were assessed.
Methods And Materials: A retrospective review of medical records from 2011 to 2018. Clinical histories and previous histological and immunohistochemical slides were collected from 24 dogs and additional immunohistochemical staining was performed as needed to assess cases of cutaneous epitheliotropic T-cell lymphoma for CD3, CD20, CD79a and PAX5 staining characteristics. Staining characteristics were assessed for their statistical relationship to median survival time.
Results: Overall median survival time was 189 days following the onset of clinical signs and 99 days following definitive diagnosis; 54% of cases had CD20 staining. There was no statistically significant correlation between staining characteristics and median survival time from onset of signs (P = 0.54) or from diagnosis (P = 0.61).
Conclusions And Clinical Significance: Canine cutaneous epitheliotropic lymphoma has a higher instance of CD20 positivity than documented previously. This indicates that CD20 staining may be unsuitable to differentiate T-cell and B-cell cutaneous epitheliotropic lymphoma. This also may have therapeutic implications with the advent of canine CD20 monoclonal antibody therapies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/vde.12703 | DOI Listing |
Vet Dermatol
December 2024
Department of Veterinary Medicine, University of Perugia, Perugia, Italy.
A 3-year-old male sugar glider presented with pruritus and alopecia primarily affecting the back and neck regions. Dermatologic diagnostics ruled out common causes. Skin biopsies revealed cutaneous epitheliotropic T-cell lymphoma, a rare condition in sugar gliders.
View Article and Find Full Text PDFCase Rep Dermatol
October 2024
Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Introduction: Cutaneous T-cell dyscrasia (CTCD) encompasses a heterogeneous group of T-cell infiltrates, often clonal and epitheliotropic. While the etiology remains unclear, certain medications, including statins, have been linked to cutaneous T-cell lymphocytic infiltrate development.
Case Description: A patient presented with a pruritic, scaly eruption on her palms and soles unresponsive to topical steroids for 1 month.
J Am Anim Hosp Assoc
September 2024
From Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts (J.L.G., S.A., G.M.-R.); and.
A 5 yr old female spayed pit bull terrier mix was evaluated for development of multiple dermal nodules over the previous 2 wk with concurrent weight loss and lethargy. A definitive diagnosis of cutaneous epitheliotropic T-cell lymphoma was obtained through histopathology and immunohistochemistry. Treatment was initiated with 32.
View Article and Find Full Text PDFAccess Microbiol
August 2024
Department of Pathobiological Sciences, University of Wisconsin-Madison School of Veterinary Medicine, Madison, WI, USA.
Vet Dermatol
October 2024
Animal Dermatology Group Inc, Tustin, California, USA.
Background: Verdinexor (Laverdia-CA1; Dechra Veterinary Products), a selective inhibitor of nuclear export, has been utilised for treatment of non-Hodgkin T-cell lymphoma in dogs. However, the efficacy of verdinexor has not been evaluated for cutaneous epitheliotropic T-cell lymphoma (CETL).
Hypothesis/objectives: To evaluate the efficacy of verdinexor for the treatment of CETL.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!